NCT00005025 2013-11-06Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal CancerNational Cancer Institute (NCI)Phase 2 Unknown